Toggle navigation
Home
Search
Services
Blog
Contact
About
Technetium Labeled Antibodies for Diagnosis
Reno, John M.
Neorx Corporation, Seattle, WA, United States
Search 3 grants from John Reno
Search grants from Neorx Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Schistosomiasis, Mucosal Immunity, and HIV Susceptibility
1/2-Neurotoxicant exposures:impact maternal and child health in Suriname-Suriname
Application of Proteomic Analysis and the Insulin Resistant Syndrome
Behavioral Treatment of Childhood Social Phobia
Glucose Sensing in Transgenic Pancreatic Islets
Recently added grants:
Uncleaved prefusion-optimized trimers on nanoparticles as HIV vaccines
Development of pH-Sensitive Probes for in vivo Cerenkov Imaging
Recombinant HIV-1 Env glycoprotein immunogens and antibodies production and structural characterization
Development of prime-boost immunization schemes to elicit VRC01-class bNAbs in polyclonal human BCR backgrounds
Evaluating anti-idiotypic antibodies as novel vaccine candidates against HIV-1
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43CM067940-001
Application #
3614580
Study Section
Project Start
1986-09-24
Project End
Budget Start
1986-11-01
Budget End
1987-03-31
Support Year
Fiscal Year
1987
Total Cost
Indirect Cost
Institution
Name
Neorx Corporation
Department
Type
DUNS #
City
Seattle
State
WA
Country
United States
Zip Code
98119
Related projects
NIH 1987
N43 CM
Technetium Labeled Antibodies for Diagnosis
Reno, John M. / Neorx Corporation
NIH 1986
N43 CM
Technetium Labeled Antibodies for Diagnosis
Reno, John M. / Neorx Corporation
Comments
Be the first to comment on this grant